Exhibit 99.1
FOR IMMEDIATE RELEASE
January 31, 2007
Owens & Minor Reports Outstanding Revenue Growth for
4th Quarter 2006, along with Rapid Progress in Converting
Recently Acquired Acute-Care Business
The company’s 2007 guidance reflects positive impact of acquisition of McKesson acute-care business
Richmond, VA….Owens & Minor (NYSE-OMI) reported revenue of $1.65 billion for the fourth quarter ended December 31, 2006, up 35.9% from $1.22 billion in the same period last year. Revenue growth in the fourth quarter included the contribution of approximately $282 million in revenue from a recent acquisition. Excluding the contribution from the acquired business, revenue grew at a very strong 12.7%.
Earnings per diluted common share (EPS) for the fourth quarter were $0.18, while net income was $7.3 million. Earnings include the following previously announced items:
| • | | Pre-tax dilution of approximately $15 million, or $0.22 per diluted share, from the transition of the recently acquired McKesson acute-care business |
| • | | A fourth quarter, pre-tax $4.7 million charge resulting from increasing the allowance for doubtful accounts receivable for the direct-to-consumer business, as well as $0.5 million in other adjustments, for a total of $0.08 per diluted share. |
“After a very busy year at Owens & Minor, we are looking forward to rapid integration of the acquired McKesson business, as well as opportunities for growing these new customer relationships in 2007,” said Craig R. Smith, president & chief executive officer of Owens & Minor. “We renewed our contracts with Novation and Broadlane and completed the customer signups in 2006, putting us in a strong position for the future. We owe our successes this past year to the contributions and dedication of our teammates and the willingness of our customers and supplier partners to work with us to optimize the efficiency of the supply chain.”
Other Fourth Quarter Results
For the quarter, gross margin was 10.6% of revenue, compared to 10.8% in the same period last year. The company attributed the slight decline in gross margin to the transition of a large volume of new and converted customer accounts. Selling, general and administrative expenses (SG&A) for the quarter, which reflected the fourth quarter charge in the direct-to-consumer business and additional costs associated with transitioning the McKesson acquisition, were 9.1% of revenue, compared to 7.8% in the same period last year.
1
2006 Full Year Results
For the full year 2006, Owens & Minor reported revenue of $5.5 billion, up 14.8% compared to revenue of $4.8 billion in 2005. Reported revenue included approximately $282 million from the recent acquisition, as discussed above. Excluding revenue from the acquisition, revenue growth was 8.9% for the year. Diluted EPS for the year was $1.20, compared to EPS of $1.61 for 2005. Net income for 2006 was $48.8 million, compared to net income of $64.4 million last year.
Earnings for 2006 were negatively affected by the following:
| • | | Pre-tax dilution of approximately $16 million, or $0.24 per share, from the transition of recently acquired business |
| • | | A second quarter pre-tax charge of $11.4 million, or $0.17 per diluted share, resulting from the company’s successful refinancing of $200 million in bonds |
| • | | Pre-tax charges and other adjustments of $9.8 million, or $0.15 per diluted share, resulting primarily from increasing the allowance for doubtful accounts receivable for the direct-to-consumer business |
Other 2006 Results
Gross margin for the year was 10.8% of revenue, improved from 10.7% in 2005. SG&A for the full year was 8.5% of revenue, compared to 7.9% last year. This increase in SG&A was driven primarily by increases in the allowance for doubtful accounts receivable for the direct-to-consumer business and the costs associated with the transition of the acute-care business, discussed above. As a result, operating earnings for 2006 were 1.9% of revenue, down from 2.4% in 2005.
Asset Management
Days sales outstanding (DSO), as of December 31, 2006, were 30.5 days, compared to 26.3 days at December 31, 2005, while inventory turns were 9.2 for the fourth quarter of 2006, compared to turns of 10.0 for the fourth quarter of 2005. The increase in DSO is largely attributable to the addition of the McKesson customer portfolio. Inventory levels at the end of the year included a temporary build-up in inventory levels in order to facilitate the smooth conversion of customers from McKesson to Owens & Minor.
In addition to the increases in working capital related to the McKesson transition, Owens & Minor used cash in 2006 to fund strong organic revenue growth, resulting in negative operating cash flow of $73.6 million for the year. Uses of cash included increased inventory levels and higher receivables.
2007 Outlook
For 2007, the company anticipates that it will report revenue growth in the 15% to 20% range and diluted EPS in a range of $1.85 to $1.95, including the impact of the acquired McKesson business. Due to the timing of the McKesson acquisition, revenue growth will be stronger in the first three quarters of 2007, while earnings growth will accelerate in the second half of the year. The dilutive effect of the McKesson transition in the first quarter of 2007 is expected to be between $9 million and $12 million.
2
“We expect to complete the conversion of the McKesson business in the first quarter and complete any needed cleanup in the second quarter, and then we see a solid opportunity for 2007,” said Smith. “We intend to serve these new customers just as we serve our existing customers, with advanced supply chain management techniques and the best distribution services available in the marketplace. Consequently, we expect to see steadily improving productivity metrics from the acquired business, as we move through the year.”
Acquisition Transition Update
Effective September 30, 2006, Owens & Minor acquired certain assets of the acute-care distribution business of McKesson Medical-Surgical for approximately $168 million, including approximately $122 million in net inventory. Owens & Minor anticipates that the acquisition will add in excess of $900 million in annual revenues to Owens & Minor.
Owens & Minor and McKesson are now at the mid-point of a comprehensive, six-month coordinated plan to transition the acute-care customers, facilities and inventory to Owens & Minor. Transition activities include complex tasks such as developing inventory demand forecasts, cross-referencing product data files, converting customers and their contracts to Owens & Minor systems, expanding selected facilities, conducting training for teammates, moving inventory to Owens & Minor facilities, and upgrading mainframe computer capacity. To date, more than 50% of the customer base has been converted and three of the acquired distribution facilities have been closed. The conversion effort has progressed smoothly and remains on schedule to be completed in March 2007, as originally planned.
2006 Highlights
Strategic Acquisitions in 2006
| • | | Owens & Minor completed the acquisition of the acute-care distribution business of McKesson Medical-Surgical Inc. |
| • | | The company completed five small asset acquisitions in 2006, adding to its direct-to-consumer business customer base |
Significant Agreements
| • | | Owens & Minor and Broadlane signed new five-year agreement, effective Feb. 1, 2007 |
| • | | Owens & Minor and Novation signed new five-year agreement, effective Sept. 1, 2006 |
| • | | Owens & Minor extended IT outsourcing contract with Perot Systems to 2014 |
3
Other Highlights
| • | | Owens & Minor completed an offering of $200 million of 6.35% Senior Notes (due 2016), successfully lowering the interest rate from 8.5% and extending the term |
| • | | Owens & Minor received an investment grade rating of “BBB-” from Fitch Ratings for the bond offering and was also assigned an investment grade of “BBB-” from Standard & Poor’s, consistent with its existing corporate credit rating |
| • | | Owens & Minor ranked #1 in DSO performance among medical suppliers (at 26.7 days for 2005, compared to the sector median of 56.0 days); The 2006 CFO Magazine Working Capital Survey, which ranked 1,000 publicly traded companies on working capital performance, was published in September 2006 |
Investors Conference Call Information & Supplemental Material
Conference Call:Owens & Minor will conduct a conference call for investors on Thursday, February 1, 2007 at 8:30 a.m. eastern time. Participants may access the call at 800-901-5241 with passcode “Owens & Minor.” A replay of the conference call will be available for five days at 888-286-8010 with passcode #29735579.Webcast:An audio-only version of the conference call will be available as a Webcast onwww.owens-minor.com under the Investor Relations section. Supporting material for 2006 results will also be provided on the Website.
Owens & Minor, Inc., (NYSE: OMI) aFORTUNE 500 company headquartered in Richmond, Virginia, is the leading distributor of national name-brand medical and surgical supplies and a healthcare supply chain management company. With a diverse product and service offering and distribution centers throughout the United States, the company serves hospitals, integrated healthcare systems, alternate care locations, group purchasing organizations, the federal government and consumers. Owens & Minor provides technology and consulting programs that enable healthcare providers to maximize efficiency and cost-effectiveness in materials purchasing, improve inventory management and streamline logistics across the entire medical supply chain—from origin of product to patient bedside. The company also has established itself as a leader in the development and use of technology. For news releases, or for more information about Owens & Minor, visit the company Web site atwww.owens-minor.com.
Safe Harbor Statement
Except for the historical information contained herein, the matters discussed in this press release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These include the ability to assimilate the operations of an acquired business into the company, the potential loss of key personnel, intense competitive pressures, such as pricing, within the healthcare industry, the success of direct marketing programs in attracting new customers, the ability to retain existing customers, changes in customer order patterns, changes in healthcare laws and regulations, changes in government, including Medicare, reimbursement guidelines and private insurer reimbursement amounts, the ability to maintain product suppliers, product price increases by suppliers and other factors discussed from time to time in the reports filed by the company with the Securities and Exchange Commission. The company assumes no obligation to update information contained in this release.
Contact: Jeff Kaczka, Senior Vice President & CFO, 804-723-7500; Richard F. Bozard, Vice President, Treasurer, 804-723-7502; Chuck Graves, Director, Finance, 804-723-7556; or Trudi Allcott, Director, Investor Communications & Media Relations, 804-723-7555.
# # # #
4
Page Five
Owens & Minor, Inc.
Consolidated Statements of Income (unaudited)
(in thousands, except ratios and per share data)
| | | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | |
| | 2006 | | | % of revenue | | | 2005 | | | % of revenue | | | % Fav(Unfav) | |
Revenue | | $ | 1,652,243 | | | 100.0 | % | | $ | 1,215,949 | | | 100.0 | % | | 35.9 | % |
Cost of revenue | | | 1,477,346 | | | 89.4 | | | | 1,085,168 | | | 89.2 | | | (36.1 | ) |
| | | | | | | | | | | | | | | | | |
Gross margin | | | 174,897 | | | 10.6 | | | | 130,781 | | | 10.8 | | | 33.7 | |
Selling, general and administrative expenses | | | 151,024 | | | 9.1 | | | | 95,086 | | | 7.8 | | | (58.8 | ) |
Depreciation and amortization | | | 9,349 | | | 0.6 | | | | 5,428 | | | 0.4 | | | (72.2 | ) |
Other operating income and expense, net | | | (1,038 | ) | | (0.1 | ) | | | 1,962 | | | 0.2 | | | (152.9 | ) |
| | | | | | | | | | | | | | | | | |
Operating earnings | | | 15,562 | | | 0.9 | | | | 28,305 | | | 2.3 | | | (45.0 | ) |
Interest expense, net | | | 5,437 | | | 0.3 | | | | 2,661 | | | 0.2 | | | (104.3 | ) |
| | | | | | | | | | | | | | | | | |
Income before income taxes | | | 10,125 | | | 0.6 | | | | 25,644 | | | 2.1 | | | (60.5 | ) |
Income tax provision | | | 2,819 | | | 0.2 | | | | 9,906 | | | 0.8 | | | 71.5 | |
| | | | | | | | | | | | | | | | | |
Net income | | $ | 7,306 | | | 0.4 | % | | $ | 15,738 | | | 1.3 | % | | (53.6 | )% |
| | | | | | | | | | | | | | | | | |
Net income per common share - basic | | $ | 0.18 | | | | | | $ | 0.40 | | | | | | | |
Net income per common share - diluted | | $ | 0.18 | | | | | | $ | 0.39 | | | | | | | |
| | | | | |
Weighted average shares - basic | | | 39,937 | | | | | | | 39,654 | | | | | | | |
Weighted average shares - diluted | | | 40,436 | | | | | | | 40,117 | | | | | | | |
| |
| | Year Ended December 31, | |
| | 2006 | | | % of revenue | | | 2005 | | | % of revenue | | | % Fav(Unfav) | |
Revenue | | $ | 5,533,736 | | | 100.0 | % | | $ | 4,822,414 | | | 100.0 | % | | 14.8 | % |
Cost of revenue | | | 4,936,940 | | | 89.2 | | | | 4,306,302 | | | 89.3 | | | (14.6 | ) |
| | | | | | | | | | | | | | | | | |
Gross margin | | | 596,796 | | | 10.8 | | | | 516,112 | | | 10.7 | | | 15.6 | |
Selling, general and administrative expenses | | | 468,789 | | | 8.5 | | | | 380,506 | | | 7.9 | | | (23.2 | ) |
Depreciation and amortization | | | 28,933 | | | 0.5 | | | | 19,252 | | | 0.4 | | | (50.3 | ) |
Other operating income and expense, net | | | (3,690 | ) | | (0.1 | ) | | | (1,078 | ) | | (0.0 | ) | | 242.3 | |
| | | | | | | | | | | | | | | | | |
Operating earnings | | | 102,764 | | | 1.9 | | | | 117,432 | | | 2.4 | | | (12.5 | ) |
Interest expense, net | | | 13,273 | | | 0.2 | | | | 11,858 | | | 0.2 | | | (11.9 | ) |
Loss on early extinguishment of debt | | | 11,411 | | | 0.2 | | | | — | | | — | | | n/ | m |
| | | | | | | | | | | | | | | | | |
Income before income taxes | | | 78,080 | | | 1.4 | | | | 105,574 | | | 2.2 | | | (26.0 | ) |
Income tax provision | | | 29,328 | | | 0.5 | | | | 41,154 | | | 0.9 | | | 28.7 | |
| | | | | | | | | | | | | | | | | |
Net income | | $ | 48,752 | | | 0.9 | % | | $ | 64,420 | | | 1.3 | % | | (24.3 | )% |
| | | | | | | | | | | | | | | | | |
Net income per common share - basic | | $ | 1.22 | | | | | | $ | 1.63 | | | | | | | |
Net income per common share - diluted | | $ | 1.20 | | | | | | $ | 1.61 | | | | | | | |
| | | | | |
Weighted average shares - basic | | | 39,860 | | | | | | | 39,520 | | | | | | | |
Weighted average shares - diluted | | | 40,467 | | | | | | | 40,056 | | | | | | | |
Page Six
Owens & Minor, Inc.
Consolidated Balance Sheets (unaudited)
(in thousands)
| | | | | | | | |
| | December 31, 2006 | | | December 31, 2005 | |
Assets | | | | | | | | |
Current assets | | | | | | | | |
Cash and cash equivalents | | $ | 5,090 | | | $ | 71,897 | |
Accounts and notes receivable, net | | | 539,178 | | | | 353,102 | |
Merchandise inventories | | | 666,527 | | | | 439,887 | |
Deferred income taxes | | | 10,065 | | | | — | |
Other current assets | | | 45,910 | | | | 29,666 | |
| | | | | | | | |
Total current assets | | | 1,266,770 | | | | 894,552 | |
Property and equipment, net | | | 70,853 | | | | 51,942 | |
Goodwill, net | | | 259,670 | | | | 242,620 | |
Intangible assets, net | | | 52,763 | | | | 18,383 | |
Deferred income taxes | | | — | | | | 170 | |
Other assets, net | | | 35,694 | | | | 32,183 | |
| | | | | | | | |
Total assets | | $ | 1,685,750 | | | $ | 1,239,850 | |
| | | | | | | | |
Current liabilities | | | | | | | | |
Accounts payable | | $ | 542,552 | | | $ | 387,833 | |
Accrued payroll and related liabilities | | | 13,472 | | | | 12,701 | |
Deferred income taxes | | | 47,606 | | | | 30,441 | |
Other accrued liabilities | | | 66,873 | | | | 57,893 | |
| | | | | | | | |
Total current liabilities | | | 670,503 | | | | 488,868 | |
Long-term debt | | | 433,133 | | | | 204,418 | |
Deferred income taxes | | | 2,472 | | | | — | |
Other liabilities | | | 32,188 | | | | 34,566 | |
| | | | | | | | |
Total liabilities | | | 1,138,296 | | | | 727,852 | |
| | | | | | | | |
Shareholders’ equity | | | | | | | | |
Common stock | | | 80,515 | | | | 79,781 | |
Paid-in capital | | | 143,557 | | | | 133,653 | |
Retained earnings | | | 332,013 | | | | 307,353 | |
Accumulated other comprehensive loss | | | (8,631 | ) | | | (8,789 | ) |
| | | | | | | | |
Total shareholders’ equity | | | 547,454 | | | | 511,998 | |
| | | | | | | | |
Total liabilities and shareholders’ equity | | $ | 1,685,750 | | | $ | 1,239,850 | |
| | | | | | | | |
Page Seven
Owens & Minor, Inc.
Consolidated Statements of Cash Flows (unaudited)
(in thousands)
| | | | | | | | |
| | Year Ended December 31, | |
| | 2006 | | | 2005 | |
Operating activities | | | | | | | | |
Net income | | $ | 48,752 | | | $ | 64,420 | |
Adjustments to reconcile net income to cash provided by operating activities: | | | | | | | | |
Depreciation and amortization | | | 28,933 | | | | 19,252 | |
Loss on early extinguishment of debt | | | 11,411 | | | | — | |
Deferred income taxes | | | 9,458 | | | | (3,930 | ) |
Provision for LIFO reserve | | | 3,944 | | | | 6,574 | |
Stock-based compensation expense | | | 5,263 | | | | 2,186 | |
Provision for losses on accounts and notes receivable | | | 23,452 | | | | 6,960 | |
Deferred direct response advertising costs | | | (9,285 | ) | | | (4,594 | ) |
Changes in operating assets and liabilities: | | | | | | | | |
Accounts and notes receivable | | | (209,011 | ) | | | (6,316 | ) |
Merchandise inventories | | | (107,965 | ) | | | (9,896 | ) |
Accounts payable | | | 137,843 | | | | 45,200 | |
Net change in other current assets and current liabilities | | | (15,944 | ) | | | 7,641 | |
Other assets | | | 106 | | | | 1,229 | |
Other liabilities | | | (170 | ) | | | 2,037 | |
Other, net | | | (367 | ) | | | 4,611 | |
| | | | | | | | |
Cash provided by (used for) operating activities | | | (73,580 | ) | | | 135,374 | |
| | | | | | | | |
Investing activities | | | | | | | | |
Additions to property and equipment | | | (21,948 | ) | | | (30,166 | ) |
Additions to computer software | | | (6,050 | ) | | | (3,641 | ) |
Acquisition of intangible assets | | | (10,735 | ) | | | (6,201 | ) |
Net cash paid for acquisitions of businesses | | | (170,680 | ) | | | (65,448 | ) |
Other, net | | | (144 | ) | | | 65 | |
| | | | | | | | |
Cash used for investing activities | | | (209,557 | ) | | | (105,391 | ) |
| | | | | | | | |
Financing activities | | | | | | | | |
Net proceeds of issuance of long-term debt | | | 198,054 | | | | — | |
Repayment of long-term debt | | | (210,459 | ) | | | — | |
Cash dividends paid | | | (24,092 | ) | | | (20,713 | ) |
Net proceeds from revolving credit facility | | | 229,100 | | | | — | |
Proceeds from exercise of stock options | | | 4,316 | | | | 4,315 | |
Excess tax benefits related to stock-based compensation | | | 1,632 | | | | — | |
Increase in drafts payable | | | 16,500 | | | | 2,823 | |
Other, net | | | 1,279 | | | | (307 | ) |
| | | | | | | | |
Cash provided by (used for) financing activities | | | 216,330 | | | | (13,882 | ) |
| | | | | | | | |
Net increase (decrease) in cash and cash equivalents | | | (66,807 | ) | | | 16,101 | |
Cash and cash equivalents at beginning of period | | | 71,897 | | | | 55,796 | |
| | | | | | | | |
Cash and cash equivalents at end of period | | $ | 5,090 | | | $ | 71,897 | |
| | | | | | | | |
Page Eight
Owens & Minor, Inc.
Financial Statistics (unaudited)
| | | | | | | | | | | | | | | | | | | | |
| | Quarter Ended | |
(in thousands, except ratios and per share data) | | 12/31/2006 | | | 9/30/2006 | | | 6/30/2006 | | | 3/31/2006 | | | 12/31/2005 | |
Operating results: | | | | | | | | | | | | | | | | | | | | |
Revenue | | $ | 1,652,243 | | | $ | 1,319,179 | | | $ | 1,300,315 | | | $ | 1,261,999 | | | $ | 1,215,949 | |
| | | | | | | | | | | | | | | | | | | | |
Gross margin | | $ | 174,897 | | | $ | 144,480 | | | $ | 141,229 | | | $ | 136,190 | | | $ | 130,781 | |
Gross margin as a percent of revenue | | | 10.6 | % | | | 11.0 | % | | | 10.9 | % | | | 10.8 | % | | | 10.8 | % |
| | | | | | | | | | | | | | | | | | | | |
SG&A expense | | $ | 151,024 | | | $ | 111,945 | | | $ | 104,764 | | | $ | 101,056 | | | $ | 95,086 | |
SG&A expense as a percent of revenue | | | 9.1 | % | | | 8.5 | % | | | 8.1 | % | | | 8.0 | % | | | 7.8 | % |
| | | | | | | | | | | | | | | | | | | | |
Operating earnings | | $ | 15,562 | | | $ | 25,550 | | | $ | 31,226 | | | $ | 30,426 | | | $ | 28,305 | |
Operating earnings as a percent of revenue | | | 0.9 | % | | | 1.9 | % | | | 2.4 | % | | | 2.4 | % | | | 2.3 | % |
| | | | | | | | | | | | | | | | | | | | |
Net income | | $ | 7,306 | | | $ | 14,454 | | | $ | 10,489 | | | $ | 16,503 | | | $ | 15,738 | |
| | | | | | | | | | | | | | | | | | | | |
Net income per common share - basic | | $ | 0.18 | | | $ | 0.36 | | | $ | 0.26 | | | $ | 0.42 | | | $ | 0.40 | |
| | | | | | | | | | | | | | | | | | | | |
Net income per common share - diluted | | $ | 0.18 | | | $ | 0.36 | | | $ | 0.26 | | | $ | 0.41 | | | $ | 0.39 | |
| | | | | | | | | | | | | | | | | | | | |
Accounts receivable: | | | | | | | | | | | | | | | | | | | | |
Accounts and notes receivable, net | | $ | 539,178 | | | $ | 391,408 | | | $ | 377,283 | | | $ | 378,066 | | | $ | 353,102 | |
| | | | | | | | | | | | | | | | | | | | |
Days sales outstanding | | | 30.5 | | | | 27.0 | | | | 24.9 | | | | 25.5 | | | | 26.3 | |
| | | | | | | | | | | | | | | | | | | | |
Inventory: | | | | | | | | | | | | | | | | | | | | |
Merchandise inventories | | $ | 666,527 | | | $ | 607,754 | | | $ | 470,230 | | | $ | 444,722 | | | $ | 439,887 | |
| | | | | | | | | | | | | | | | | | | | |
Average inventory turnover | | | 9.2 | | | | 9.7 | * | | | 10.1 | | | | 10.3 | | | | 10.0 | |
| | | | | | | | | | | | | | | | | | | | |
Financing: | | | | | | | | | | | | | | | | | | | | |
Long-term debt | | $ | 433,133 | | | $ | 326,928 | | | $ | 197,698 | | | $ | 203,009 | | | $ | 204,418 | |
| | | | | | | | | | | | | | | | | | | | |
Stock information: | | | | | | | | | | | | | | | | | | | | |
Cash dividends per common share | | $ | 0.15 | | | $ | 0.15 | | | $ | 0.15 | | | $ | 0.15 | | | $ | 0.13 | |
| | | | | | | | | | | | | | | | | | | | |
Stock price at quarter-end | | $ | 31.27 | | | $ | 32.89 | | | $ | 28.60 | | | $ | 32.77 | | | $ | 27.53 | |
| | | | | | | | | | | | | | | | | | | | |
* | Excludes the impact of the McKesson acquisition |